This inventor holds 2 USPTO granted patents. Top assignee: Dyax Corporation. Active years: 2006-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2015
Title: Maria Grazia De Simoni: Innovator in Kallikrein-Inhibitor Therapies
Introduction
Maria Grazia De Simoni is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of medical therapies, particularly in the area of kallikrein-inhibitor therapies. With a total of 2 patents to her name, her work focuses on methods to prevent or reduce ischemia and reperfusion injury.
Latest Patents
Her latest patents include innovative methods for preventing or reducing ischemia, such as cerebral ischemia, and addressing reperfusion injury associated with cerebral ischemia. These therapies aim to improve patient outcomes in critical medical situations.
Career Highlights
Maria Grazia De Simoni is currently associated with Dyax Corporation, where she continues to advance her research and development efforts. Her work has garnered attention for its potential impact on patient care and treatment methodologies.
Collaborations
Throughout her career, she has collaborated with notable professionals in her field, including Robert Charles Ladner and Arthur Charles Ley. These partnerships have contributed to the advancement of her research and the successful development of her patents.
Conclusion
Maria Grazia De Simoni stands out as an influential inventor in the realm of kallikrein-inhibitor therapies. Her innovative approaches and dedication to improving medical treatments highlight her significant role in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile